Literature DB >> 33030695

Epoxyquinophomopsins A and B from endophytic fungus Phomopsis sp. and their activity against tyrosine kinase.

Elvira Hermawati1, Suzany D Ellita2, Lia D Juliawaty2, Euis H Hakim2, Yana M Syah2, Hayato Ishikawa3.   

Abstract

Two new quinone derivatives, epoxyquinophomopsins A (1) and B (2), were purified from the EtOAc extract of endophytic fungus Phomopsis sp isolated from Morus cathayana. The structures of both compounds were determined based on 1D and 2D NMR and mass spectral data, as well as by x-ray diffraction analysis for 1. Compounds 1 and 2 were screened against eight receptor- (RTKs) and eight non-receptor tyrosine kinases (nRTKs). Both compounds showed strong inhibitory properties against Bruton's Tyrosine Kinase (nRTK) with their kinase activity were 19% and 20%, respectively. Only compound 1 that showed strong inhibitory properties against RTKs EGFR and HER-4 with its kinase activity were 16 and 15%, respectively. Thus, both compounds have potential as tyrosine kinase inhibitors.

Entities:  

Keywords:  Epoxyquinophomopsin A; Morus cathayana; Non-receptor tyrosine kinase; Phomopsis sp.; Receptor tyrosine kinase; epoxyquinophomopsin B

Year:  2020        PMID: 33030695     DOI: 10.1007/s11418-020-01454-1

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  1 in total

1.  Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals.

Authors:  Arabinda Ghosh; Nobendu Mukerjee; Bhavdeep Sharma; Anushree Pant; Yugal Kishore Mohanta; Rahul D Jawarkar; Ravindrakumar L Bakal; Ermias Mergia Terefe; Gaber El-Saber Batiha; Gomaa Mostafa-Hedeab; Nisreen Khalid Aref Albezrah; Abhijit Dey; Debabrat Baishya
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.